Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
-
* Corresponding author: Galina Volgareva gmvolgareva@front.ru
1 Institute of Carcinogenesis, N.N.Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia
2 P.A.Gertzen Institute of Oncology, Russian Ministry of Health, Moscow 125284, Russia
3 Chair of Obstetrics and Gynecology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
4 Kourion Therapeutics AG, Langenfeld, Germany
5 Institute of Clinical Oncology, N.N.Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia
BMC Cancer 2004, 4:58 doi:10.1186/1471-2407-4-58
Published: 31 August 2004Additional files
Additional File 1:
Data on high risk HPV genome detection by PCR in CIN I and CIN II samples. the data are presented on high-risk HPV genetic material detection in 9 CIN I and 9 CIN II samples.
Format: XLS Size: 16KB Download file
This file can be viewed with: Microsoft Excel Viewer
